Skip to main content
HALEOS LABS LIMITED logo

HALEOS LABS LIMITED — Investor Relations & Filings

Ticker · HALEOSLABS ISIN · INE320X01016 LEI · 335800DGMSN4RZ5D8N90 BSE.NS Telecommunications, computer programming, consultancy, computing infrastructure, and other information service activities
Open in API
Filings indexed 458 across all filing types
Latest filing 2019-10-21 Regulatory Filings
Country IN India
Listing BSE.NS HALEOSLABS

About HALEOS LABS LIMITED

https://www.haleoslabs.com

Haleos Labs Limited is a technology-driven enterprise focused on providing comprehensive software development and information technology solutions. The company specializes in the design, development, and implementation of custom software applications, web-based platforms, and digital transformation strategies. Its core competencies include software engineering, system integration, and the maintenance of complex digital infrastructures. Haleos Labs Limited serves a diverse range of clients by delivering scalable technological frameworks and innovative research-led solutions aimed at optimizing operational efficiency and enhancing digital presence. The firm emphasizes technical excellence and the application of modern development methodologies to address evolving business requirements in the digital landscape.

Recent filings

Filing Released Lang Actions
Updates
Regulatory Filings Classification · 95% confidence The document is a certificate issued under regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, confirming compliance related to dematerialization of securities for a specific period (01-07-2019 to 30-09-2019). It is addressed to stock exchanges and is signed by the company secretary and the registrar & transfer agent. The document is short (2651 characters) and serves as a compliance certificate rather than a financial report or detailed filing. It does not contain financial statements, management discussion, or audit information. It is a regulatory compliance certificate related to securities and share transfer regulations, fitting best under Regulatory Filings (RNS) as a miscellaneous regulatory announcement.
2019-10-21 English
Disclosure under SEBI Takeover Regulations
Regulatory Filings Classification · 95% confidence The document is a detailed disclosure by SMS Lifesciences India Limited regarding the reasons for encumbrance by promoters, including specifics about pledged shares, encumbrance percentages, entities involved, and related agreements. It references SEBI circulars and provides comprehensive data on share encumbrance events. This type of disclosure is regulatory in nature, related to share encumbrance by promoters, and does not constitute a financial report, earnings release, or management discussion. It is not a report publication announcement since it contains substantive detailed information rather than just a notice. The document fits best under Regulatory Filings (RNS) as it is a compliance disclosure mandated by SEBI and does not fall under other more specific categories like Major Shareholding Notification or Director's Dealing, which are more about share ownership changes or insider trades. Therefore, the classification is Regulatory Filings (RNS) with high confidence.
2019-10-11 English
Updates
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges (NSE and BSE) providing an update on the price movement of the company's stock and regulatory status of a product (Ranitidine HCL). It references previous communications including AGM proceedings but does not contain any financial statements, detailed financial data, or comprehensive report content. The document is short (2289 characters) and serves as a regulatory update or clarification rather than a full report. It fits best as a Regulatory Filing (RNS) since it is a general regulatory announcement and does not meet criteria for other specific report types.
2019-10-10 English
Shareholders meeting
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a formal communication addressed to stock exchanges regarding the voting results of the 13th Annual General Meeting (AGM) of SMS Lifesciences India Limited. It includes detailed voting outcomes on agenda items, references to the SEBI (Listing Obligations and Disclosure Requirements) Regulation 44(3), and a scrutinizer's report. The content focuses on the official announcement of shareholder voting results from the AGM, not the AGM materials themselves or the full annual report. The document length is about 15,000 characters, which is consistent with a detailed voting results announcement. Therefore, the document fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA).
2019-10-01 English
Trading Window
Regulatory Filings Classification · 95% confidence The document is a formal letter addressed to stock exchanges informing about the closure of the trading window for insiders due to upcoming financial results announcement. It references the SEBI (Prohibition of Insider Trading) Regulations and specifies the period of closure related to the quarter and half year ended 30th September 2019. The content is an announcement about trading restrictions, not a financial report or detailed filing. The document length is short (1436 characters) and it does not contain financial data or detailed report content. Therefore, it is best classified as a Regulatory Filing (RNS), which covers miscellaneous regulatory announcements that do not fit other categories.
2019-09-30 English
Updates
AGM Information Classification · 95% confidence The document is titled 'Proceedings of the 13th Annual General Meeting of the Company held on 30th September, 2019.' It details the conduct of the AGM, including the chairman's speech, voting procedures, agenda items discussed, and the conclusion of the meeting. It does not contain the full annual report or financial statements but rather a summary of the meeting proceedings. This matches the definition of AGM Information (AGM-R), which includes presentations and materials shared during the AGM. The document length is 4883 characters, which is sufficient to include detailed proceedings rather than just an announcement. Therefore, the correct classification is AGM-R with high confidence.
2019-09-30 English

Browse filings by year

10 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.